|
|
News for Healthier Living
SITC 2026: UT MD Anderson Highlights Advances in Cancer Immunotherapy
Researchers from The University of Texas MD Anderson Cancer Center highlighted promising advances in cancer immunotherapy at the 2026 Society for Immunotherapy of Cancer (SITC) Annual Meeting. The presentations showcased early-phase clinical trials and preclinical studies exploring new approaches to treating advanced cancers, including solid tumors, brain cancer and melanoma. These studies offer new insights to improve the effectiveness of immunotherapies and expand treatment options for patients.
November 9, 2026
November 9 2026November 8 2026November 7 2026November 6 2026November 5 2026November 4 2026November 3 2026November 2 2026November 1 2026October 30 2026October 29 2026October 28 2026October 27 2026October 26 2026
|
|
|
|
|